文献速递腹部泌尿生殖CT

孤立性主胰管扩张:良性与恶性病因的CT鉴别

Isolated Main Pancreatic Duct Dilatation: CT Differentiation Between Benign and Malignant Causes.
PubMed 文献 · AJR Am J Roentgenol · 2017-08-31

回顾性纳入41例CT上无可见肿块孤立性主胰管扩张患者,分析良恶性病因的CT鉴别特征,并评估放射科医师知晓这些特征后诊断效能是否提高。恶性扩张更常表现为长(≥6.1 mm)而突然的移行、无导管穿透征、密度差及胰管或胆总管强化;知晓这些特征后部分医师AUC显著提高。

要点

  • 良性主胰管扩张移行区多位于胰头,且移行段短(<6.1 mm)、光滑;导管穿透征仅见于良性扩张。
  • 恶性主胰管扩张更常伴密度差及胰管或胆总管强化,移行段长(≥6.1 mm)且突然。
  • 知晓上述CT特征后,三位医师中两位AUC显著提高,一位AUC提高但未达统计学显著。

核心结论

  • 远端、长(≥6.1 mm)且突然的移行、无导管穿透征、存在密度差及胰管或胆总管强化是提示恶性而非良性主胰管扩张的CT征象。
  • 知晓这些高度提示性的CT标准后,放射科医师鉴别良恶性主胰管扩张的诊断效能显著提高。

研究设计与样本

  • 回顾性研究,2000年1月至2016年10月纳入41例CT上无可见肿块的孤立性主胰管扩张患者。
  • 两名放射科医师共识阅片,评估移行区位置、形态(光滑 vs 突然)、移行段长度、扩张胰管直径、导管穿透征、实质萎缩、密度差、伴随胰腺炎、钙化、胰管或胆总管强化及病灶周围囊肿。
  • 另由三名专业背景不同的审阅者独立进行两轮鉴别诊断阅片,采用5点信心量表;第一轮不提供鉴别信息,第二轮知晓单因素分析结果。
  • 采用ROC曲线配对比较评估放射科医师诊断效能;统计方法包括卡方检验、Fisher精确检验和t检验。

关键影像表现/征象

  • 良性主胰管扩张的移行区多位于胰头(良性57.9%[11/19] vs 恶性13.6%[3/22],p=0.003)。
  • 良性主胰管扩张移行段长度多<6.1 mm(良性78.9%[15/19] vs 恶性9.1%[2/22],p<0.0001),且多呈光滑移行(良性89.5%[17/19] vs 恶性9.1%[2/22],p<0.0001)。
  • 导管穿透征仅见于良性主胰管扩张(良性73.7%[14/19] vs 恶性0%[0/22],p<0.0001)。
  • 恶性主胰管扩张更常伴密度差(恶性63.6%[14/22] vs 良性10.5%[2/19],p=0.001)。
  • 恶性主胰管扩张更常伴胰管或胆总管强化(恶性36.4%[8/22] vs 良性0%[0/19],p=0.003)。

诊断标准与关键数值

  • 恶性主胰管扩张的移行段长度阈值为≥6.1 mm,良性主胰管扩张多<6.1 mm(良性78.9%[15/19] vs 恶性9.1%[2/22],p<0.0001)。
  • 知晓显著CT特征后,三名审阅者AUC分别从0.653、0.587、0.884升至0.864、0.964、0.908(p=0.013、p<0.0001、p=0.701)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study is to retrospectively evaluate the differential CT features of isolated benign and malignant main pancreatic duct (MPD) dilatation and to investigate whether the diagnostic performance of radiologists can be improved with knowledge of these differential CT features.

MATERIALS AND METHODS: Forty-one patients who had isolated MPD dilatation without any visible mass on CT from January 2000 to October 2016 were retrospectively enrolled in the study. Two radiologists reviewed CT images in consensus for the location, shape (smooth vs abrupt), length of transition, dilated pancreatic duct (PD) diameter, presence of duct penetrating sign, parenchymal atrophy, attenuation difference, associated pancreatitis, calcification, PD or common bile duct (CBD) enhancement, and perilesional cyst. The chi-square test, Fisher exact test, and t test were used to find the differential CT features of benign and malignant MPD dilatation. Two successive review sessions for differentiation between the two disease entities were then independently performed by three other reviewers with differing expertise, with the use of a 5-point confidence scale. The first session provided no information for differentiation; however, reviewers were aware of the results of univariate analyses in the second session. The diagnostic performance of the radiologists was evaluated using a pairwise comparison of ROC curves.

RESULTS: A total of 19 benign and 22 malignant MPD dilatations were identified. In patients with benign MPD dilatation, transition areas were frequently located in the head (57.9% [11/19] vs 13.6% [3/22], p = 0.003) and showed significantly shorter (< 6.1 mm) (78.9% [15/19] vs 9.1% [2/22], p < 0.0001) and smooth transition (89.5% [17/19] vs 9.1% [2/22], p < 0.0001). Duct penetrating sign was exclusively observed in patients with benign MPD dilatation (73.7% [14/19] vs 0% [0/22], p < 0.0001). In contrast, malignant MPD dilatation frequently was accompanied by attenuation difference (63.6% [14/22] vs 10.5% [2/19], p = 0.001) and associated PD or CBD enhancement (36.4% [8/22] vs 0% [0/19], p = 0.003). The AUC values of three reviewers significantly increased from 0.653, 0.587, and 0.884 to 0.864, 0.964, and 0.908, respectively, with knowledge of significant CT features (p = 0.013, p < 0.0001, and p = 0.701, respectively).

CONCLUSION: Distal, long (≥ 6.1 mm), and abrupt transition, the absence of duct penetrating sign, and the presence of attenuation difference and PD or CBD enhancement were highly suggestive CT findings for differentiation of malignant from benign MPD dilatation. The diagnostic performance of radiologists with regard to differentiation was significantly improved with knowledge of these highly suggestive CT criteria.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Kim SW, Kim SH, Lee DH, et al. Isolated Main Pancreatic Duct Dilatation: CT Differentiation Between Benign and Malignant Causes. AJR Am J Roentgenol. 2017. PMID: 28858540. doi:10.2214/AJR.17.17963

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。